首页> 外文期刊>Cellular and molecular biology >Mutation spectrum of beta-globin gene in thalassemia patients at Hasan Sadikin Hospital - West Java Indonesia
【24h】

Mutation spectrum of beta-globin gene in thalassemia patients at Hasan Sadikin Hospital - West Java Indonesia

机译:哈斯血症患者β-珠蛋白基因的突变谱 - 西爪哇印度尼西亚

获取原文
获取原文并翻译 | 示例
           

摘要

Thalassemia is the most common hereditary haemolytic anemia in Southeast Asia, in which Indonesia is among countries that are at a high risk for thalassemia. It has been reported that mutation in the beta-globin gene is responsible in severe Thalassemia. However, the spectrum of beta-globin gene mutations in Indonesian population varies in different regions. Thus, this study aimed to identify the most prevalent mutation of Thalassemia patients from the Hasan Sadikin Hospital, Bandung, using this as a reference hospital for Thalassemia in West Java. The three most prevalent mutations of beta globin (IVS1nt5, Cd26 (HbE), and IVS1nt1), were conducted in the beginning of this study. Mutations of 291 samples were detected by PCR-RFLP in the Molecular Genetic Laboratory, Faculty of Medicine Universitas Padjadjaran, Bandung. The prevalence of the beta globin gene mutation types were 47.4% IVS1nt5 homozygote, 9.9% compound heterozygote IVS1nt5/HbE, 5.4% compound heterozygote IVS1nt5/IVS1nt1, 1.4% compound heterozygote HbE/IVS1nt1, 1% HbE homozygote, 14.4% Compound heterzygote IVS1nt5/. . . (no paired mutation), 2.06% compound heterozygote HbE/. . . (no paired mutation), 1.3% compound heterozygote IVS1nt1/. . . (no paired mutation), and 7 samples were unidentified. The thalassemia mutation IVS1nt5 homozygote is the most common mutation found in Thalassemia patients at Hasan Sadikin Hospital, Bandung. The samples with unidentified results might carry mutations other than the three that are observed in the present study.
机译:地中海贫血是东南亚最常见的遗传性溶血性贫血,其中印度尼西亚是地中海贫血风险高的国家。据报道,β-珠蛋白基因的突变在严重的丘脑中负责。然而,印度尼西亚群体中β-珠蛋白基因突变的谱不同不同。因此,本研究旨在鉴定来自哈桑萨曼医院,万隆患者的最普遍的突变,用这是西爪哇省西爪哇群岛的参考医院。在本研究开始,对β珠蛋白(IVS1NT5,CD26(HBE)和IVS1NT1)的三种最普遍的突变进行了进行。 PCR-RFLP在Molecular遗传实验室,Medicinitas Padjadjaran,Bandung的分子遗传实验室中检测到291个样品的突变。 β球蛋白基因突变类型的患病率为47.4%IVS1NT5纯合子,9.9%化合物杂合子IVS1NT5 / HBE,5.4%化合物杂合子IVS1NT5 / IVS1NT1,1.4%复合杂合子HBE / IVS1NT1,1%HBE HOMOZYGOTE,14.4%复合杂血抗素IVS1NT5 / 。 。 。 (无成对突变),2.06%复合杂合子术HBE /。 。 。 (无成对突变),1.3%复合杂合子素IVS1NT1 /。 。 。 (无成对突变)和7个样品未识别。地中海血症突变IVS1NT5 Homozygote是Hasan Sadikin Hospital,Bandung的患者中最常见的突变。具有未鉴定结果的样品可能携带除本研究中观察到的三种之外的突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号